# clm_8AB184162D82

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 3,076,400,000 United States dollar  
valid_from: 2025-09-30  
valid_to: 2026-03-31  
published: 2025-11-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_78B1FE0A2ECC  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly revenue: 3,076,400,000 United States dollar", as of 2025-09-30 (until 2026-03-31). Claim clm_8AB184162D82, https://asof.is/claim/clm_8AB184162D82, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532025000232/0000875320-25-000232-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2025, filed 2025-11-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532025000232/0000875320-25-000232-index.htm (primary, SEC EDGAR 10-Q Q3 FY2025, published 2025-11-04)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_revenue | 2,964,700,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_8AB184162D82](/claim/clm_8AB184162D82.md) | [clm_9B7DD75E016B](/claim/clm_9B7DD75E016B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.